January

January 17, 2015

MiRNA-based molecular therapy for Acute Myeloid Leukeima (AML): NRF2 suppresses the expression of 5-Lipoxygenase (5-LO) and inhibits cancer stem cell proliferation via up regulation of its target gene, 17/January/2015, 18.02

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based molecular therapy for  Acute Myeloid Leukeima (AML): NRF2 suppresses the expression of 5-Lipoxygenase (5-LO) and inhibits […]
January 17, 2015

MiRNA-based therapy for pulmonary arterial hypertension: MiRNA-150 inhibits the development of pulmonary arterial hypertension via down regulation of its target gene, 17/November/2014, 17.37

A study from the University of California, La Jolla, CA, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 […]
January 17, 2015

Molecular therapy for Pulmonary Hypertension: p63 and p73 inhibit pulmonary hypertension via up regulation of their target genes, 17/January/2015, 14.16

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular therapy for Pulmonary Hypertension: p63 and p73 inhibit pulmonary hypertension via up regulation of their target […]
January 17, 2015

MiRNA-based molecular therapy for T2DM: Stem cell protein Oct-4 promotes insulin secretion and inhibits glucose intolerance via down regulation of FFA2 and FFA3, 17/November/2014, 10.56 am

A recent study from the Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany shows that “Loss of FFA2 and FFA3 increases insulin secretion and improves […]